Author:
Thomas Holly R.,Ezzeldin Hany H.,Guarcello Vincenzo,Mattison Lori K.,Fridley Brooke L.,Diasio Robert B.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics
Reference36 articles.
1. Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy;Lu;Cancer Res,1993
2. Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors;J Clin Oncol,1998
3. Clinical pharmacokinetics of 5-fluorouracil and its metabolism in plasma, urine, and bile;Heggie;Cancer Res,1987
4. Importance of dihydropyrimidine dehydrogenase (DPD) deficiency in patients exhibiting toxicity following treatment with 5-fluorouracil;Johnson;Adv Enzyme Regul,2001
5. A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution;Hamajima;Gene,1996
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献